Risk analysis for deterioration of renal function after pancreas alone transplant

Chatzizacharias NA, Vaidya A, Sinha S, Sharples E, Smith R, Jones G, Brockmann J, Friend PJ. Risk analysis for deterioration of renal function after pancreas alone transplant. 
Clin Transplant 2011 DOI: 10.1111/j.1399‐0012.2011.01534.x. 
© 2011 John Wiley & Sons A/S. :  The risk of progression t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical transplantation 2012-05, Vol.26 (3), p.387-392
Hauptverfasser: Chatzizacharias, Nikolaos A., Vaidya, Anil, Sinha, Sanjay, Sharples, Edward, Smith, Richard, Jones, Gareth, Brockmann, Jens, Friend, Peter J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Chatzizacharias NA, Vaidya A, Sinha S, Sharples E, Smith R, Jones G, Brockmann J, Friend PJ. Risk analysis for deterioration of renal function after pancreas alone transplant. 
Clin Transplant 2011 DOI: 10.1111/j.1399‐0012.2011.01534.x. 
© 2011 John Wiley & Sons A/S. :  The risk of progression to renal replacement after pancreas transplant alone (PTA) is a concern in patients with pre‐transplant estimated glomerular filtration rate (eGFR) 12 mg/dL) at six months post‐transplant was the only independent risk factor identifying a substantial decline in native renal function by Cox regression analysis (HR = 14.300, CI = 1.271–160.907, p = 0.031). The presence of severe pre‐transplant proteinuria (urine Pr/Cr ≥100 mg/mmol) marginally failed to reach significance (p = 0.056). Low eGFR levels alone (≤45 and ≤40 mL/min/1.73 m2) at the time of transplant did not correlate with substantial decline in renal function. Our data suggest that PTA is a justifiable therapy for patients with hypoglycemia unawareness or other life‐threatening diabetic complications, even in those with borderline renal function, provided that they do not suffer from severe proteinuria and appropriate monitoring and tailoring of immunosuppression is ensured.
ISSN:0902-0063
1399-0012
DOI:10.1111/j.1399-0012.2011.01534.x